In recent trading session, Allarity Therapeutics Inc (NASDAQ:ALLR) saw 72.22 million shares changing hands at last check today with its beta currently measuring 0.49. Company’s recent per share price level of $1.67 trading at $0.3 or 21.83% at last check today assigns it a market valuation of $0.78M. That closing price of ALLR’s stock is at a discount of -22175.45% from its 52-week high price of $372.00 and is indicating a premium of 31.14% from its 52-week low price of $1.15. Taking a look at company’s average trading volume volume of 549.99K if we extend that period to 3-months.

Allarity Therapeutics Inc (NASDAQ:ALLR) trade information

Upright in the green today for gaining 21.83%, in the last five days ALLR remained trading in the green while hitting it’s week-highest on Thursday, 05/02/24 when the stock touched $1.67 price level, adding 51.73% to its value on the day. Allarity Therapeutics Inc’s shares saw a change of -84.86% in year-to-date performance and have moved 16.72% in past 5-day. Allarity Therapeutics Inc (NASDAQ:ALLR) showed a performance of -64.26% in past 30-days.

Allarity Therapeutics Inc (ALLR) estimates and forecasts

Statistics highlight that Allarity Therapeutics Inc is scoring comparatively higher than the scores of other players of the relevant industry. The company lost -85.02% of value to its shares in past 6 months, showing an annual growth rate of 86.06% while that of industry is 12.60. Apart from that, the company came raising its revenue forecast for fiscal year 2024.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 57.56% during past 5 years.

ALLR Dividends

Allarity Therapeutics Inc is more likely to be releasing its next quarterly report in June and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.